510(k) · Cleared
ClearedTD-4277 Blood Glucose Monitoring System, Model 4277
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Taidoc Technology Corporation · NBW System, Test, Blood Glucose, Over The Counter
Cleared on Jun 28, 2010 as substantially equivalent to K082169 (Taidoc Technology Corporation, 2008) and 1 other predicate after a 144-day review. Its family tree reaches back 3 generations to 2003. 6 later devices descend from it.
- Decided
- Jun 28, 2010
- Review
- 144 days
- Class
- Class II
- Product code
- NBW
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 3 generations to K031755 (2003). 5 ancestors in all. 6 later devices descend from it, 5 citing it directly.
- Root · 3 generations backK031755 Accu-Chek Compact Test StripRoche Diagnostics Corp. · 2003
- 2 generations backK040796 Accu-Chek GO SystemRoche Diagnostics Corp. · 2004 · Recalled
- 1 generation backK082169 Pro Glucose Test StripTaidoc Technology Corporation · 2008
- This deviceK100322 TD-4277 Blood Glucose Monitoring System, Model 4277Taidoc Technology Corporation · 2010
- Descendant · cites it directly · 1 of its ownK190579 TD-4183 Blood Glucose Monitoring SystemTaidoc Technology Corporation · 2019
- Descendant · 2 generations on · 0 of its ownK222126 VivaChek™ Fad Blood Glucose Monitoring System, VivaChek™ Fad Smart…Vivachek Biotech (Hangzhou) Co., Ltd. · 2024
- Descendant · cites it directly · 0 of its ownK181588 POPS! one Blood Glucose Monitoring SystemTaidoc Technology Corporation · 2018
- Descendant · cites it directly · 0 of its ownK173511 ActiveCare TD-4121 Blood Glucose Monitoring SystemTaidoc Technology Corporation · 2018
- Descendant · cites it directly · 0 of its ownK113768 U-Right TD-4280 Blood Glucose Monitoring SystemTaidoc Technology Corporation · 2012
Showing 5 of 6 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 6 · See all- K190579TD-4183 Blood Glucose Monitoring SystemTaidoc Technology Corporation · 2019 · cites it directly1descendant
- K222126VivaChek™ Fad Blood Glucose Monitoring System, VivaChek™ Fad Smart Blood Glucose…Vivachek Biotech (Hangzhou) Co., Ltd. · 2024 · 2 generations on0descendants
- K181588POPS! one Blood Glucose Monitoring SystemTaidoc Technology Corporation · 2018 · cites it directly0descendants
- K173511ActiveCare TD-4121 Blood Glucose Monitoring SystemTaidoc Technology Corporation · 2018 · cites it directly0descendants
- K113768U-Right TD-4280 Blood Glucose Monitoring SystemTaidoc Technology Corporation · 2012 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K031755 | Accu-Chek Compact Test Strip | Roche Diagnostics Corp. | 2003 | — |
| −2 | K040796 | Accu-Chek GO System | Roche Diagnostics Corp. | 2004 | 2 |
| −1 | K082169 | Pro Glucose Test Strip | Taidoc Technology Corporation | 2008 | — |
| 0 (this device) | K100322 | TD-4277 Blood Glucose Monitoring System, Model 4277 | Taidoc Technology Corporation | 2010 | — |
| +1 | K190579 | TD-4183 Blood Glucose Monitoring System | Taidoc Technology Corporation | 2019 | — |
| +2 | K222126 | VivaChek™ Fad Blood Glucose Monitoring System, VivaChek™ Fad Smart Blood… | Vivachek Biotech (Hangzhou) Co., Ltd. | 2024 | — |
| +1 | K181588 | POPS! one Blood Glucose Monitoring System | Taidoc Technology Corporation | 2018 | — |
| +1 | K173511 | ActiveCare TD-4121 Blood Glucose Monitoring System | Taidoc Technology Corporation | 2018 | — |
| +1 | K113768 | U-Right TD-4280 Blood Glucose Monitoring System | Taidoc Technology Corporation | 2012 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 1 | 0 |
| 2009 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2012 | 2 | 0 |
| 2018 | 2 | 0 |
| 2019 | 1 | 0 |
| 2024 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new NBW device
- #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K082169 | Pro Glucose Test StripSummary page 2…r as a system to produce accurate blood glucose test results. 5. Substantial Equivalence Information: A. Predicate device name: TaiDoc Pro I Glucose Test Strip, k082169 FORA 030 blo od glucose monitoring system, k0901 87 B. Comparison with predicate:I The TD-4277 BLOOD GLUCOSE MONITORI… | 2008 |
| * | K090187 | Fora G30 Blood Glucose Monitoring System, Model TD-4241Summary page 2…sults. 5. Substantial Equivalence Information: A. Predicate device name: TaiDoc Pro I Glucose Test Strip, k082169 FORA 030 blo od glucose monitoring system, k0901 87 B. Comparison with predicate:I The TD-4277 BLOOD GLUCOSE MONITORING SYSTEM MODEL TD-4277 has the equivalent technolog… | 2009 |
What descends from it? (6)
5 later devices cite it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K190579 | TD-4183 Blood Glucose Monitoring System | 2019 | 1 |
| K181588 | POPS! one Blood Glucose Monitoring System | 2018 | 0 |
| K173511 | ActiveCare TD-4121 Blood Glucose Monitoring System | 2018 | 0 |
| K113768 | U-Right TD-4280 Blood Glucose Monitoring System | 2012 | 0 |
| K111890 | Fora Diamond Prima Blood Glucose Monitoring System, Fora Diamond Mini Blood Glucose… | 2012 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 1.6 years on median.
- 1 of the 5 ancestors has a recall of any class.
- Of its descendants, K190579 (Taidoc Technology Corporation, 2019) has gone furthest, with 1 descendant of its own.
- 2 other devices also cite its predicate K082169.
How does its category compare?
All NBW devicesNBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.
FDA decisions per year · NBW
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · NBW
243in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · NBW
1in 2025
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · NBW
4,745in 2025
MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 29 | 85 | 9 | 7,991 |
| 2008 | 37 | 128 | 2 | 7,704 |
| 2009 | 38 | 140 | 5 | 10,963 |
| 2010 | 31 | 132 | 11 | 11,631 |
| 2011 | 30 | 328 | 1 | 22,909 |
| 2012 | 30 | 230 | 1 | 23,449 |
| 2013 | 47 | 167 | 5 (2) | 35,408 |
| 2014 | 24 | 202 | 1 | 38,524 |
| 2015 | 32 | 237 | 0 | 62,111 |
| 2016 | 20 | 233 | 1 | 76,621 |
| 2017 | 25 | 244 | 0 | 37,538 |
| 2018 | 19 | 168 | 0 | 16,911 |
| 2019 | 10 | 127 | 14 | 14,472 |
| 2020 | 7 | 121 | 0 | 10,703 |
| 2021 | 7 | 465 | 0 | 9,198 |
| 2022 | 12 | 410 | 0 | 8,103 |
| 2023 | 5 | 193 | 0 | 7,256 |
| 2024 | 7 | 243 | 0 | 6,220 |
| 2025 | 2 | — | 1 | 4,745 |
| 2026 | 5 | 190 | 0 | — |
What is it indicated for?
TD-4277 Blood Glucose Monitoring System, Model TD-4277 is intended for use in the quantitative measurement of glucose in fresh capillary whole blood from the finger. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of diabetes control program. It is not intended for the diagnosis of or screening for diabetes mellitus, and is not intended for use on neonates.
Professionals may use the test strips to test capillary and venous blood samples, but lay user may not test venous blood samples.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K100322 · printed Nov 6, 2026
Cite this page
510(k) Report. “K100322: TD-4277 Blood Glucose Monitoring System, Model 4277.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K100322
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026